14.06.2023
Publications category: MIDD
14.06.2023
A Physiologically-Based Pharmacokinetic Framework for Prediction of Drug Exposure in Malnourished Children
14.06.2023
Lumenfantrine Exposure in Malnourished Children: PBPK Modeling Applied for Predictions and Dose Adjustments
14.06.2023
Enhancing Efficiency and Decision Quality in Parkinson’s Disease Drug Trials for LRRK2 Programs Using Item Response Modelling
14.06.2023
Pharmacokinetic Modelling and Simulation Support the Age and Body-Weight-Adjusted Dosing of Dabigatran Etexilate in Paediatric Patients with Venous Thromboembolism, PB1271
14.06.2023
Caplacizumab Model-Based Dosing Recommendations In Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura
14.06.2023
Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients with Acquired Thrombotic Thrombocytopenic Purpura, PB2249
14.06.2023
Effect of Plasma Exchange on the Pharmacokinetics and Pharmacodynamics of Caplacizumab, PS1487
14.06.2023
Assessment of Expected Drug Exposure Relative Maximum Safety Limits in Early Phase Studies
14.06.2023
Caplacizumab Dosing Rational in aTTP Patients Supported by Mechanism Based PKPD Modelling
14.06.2023